Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Lexaria Bioscience Corp. - Common Stock (NQ:LEXX)

1.030 UNCHANGED

Streaming Delayed Price Updated: 12:17 PM EDT, Jul 24, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	89,281
Open	1.020
Bid (Size)	1.030 (322)
Ask (Size)	1.040 (27)
Prev. Close	1.030
Today's Range	1.010 - 1.050
52wk Range	0.7941 - 4.380
Shares Outstanding	17,559,179
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Lexaria's DehydraTECH Technology Has the Potential to Unlock Accelerated Revenue Growth in the GLP-1-Industry

July 23, 2025

Via ACCESS Newswire

12 Health Care Stocks Moving In Friday's After-Market Session

July 18, 2025

Via Benzinga

Performance

YTD	-55.2%	-55.2%
1 Month	+6.5%	+6.5%
3 Month	-35.2%	-35.2%
6 Month	-48.0%	-48.0%
1 Year	-65.9%	-65.9%

More News

Lexaria Reaches Patent Milestone - 50 Patents Now Granted Worldwide

June 23, 2025

Via ACCESS Newswire

Lexaria's DehydraTECH-Liraglutide Human GLP-1 Clinical Study Supports Pathway to Potential FDA Registration as an Orally-Delivered Capsule

June 11, 2025

Via ACCESS Newswire

Lexaria Attending BIO International Convention

June 05, 2025

Via ACCESS Newswire

The Global Revolution in Healthcare Driven by GLP-1 Drugs and the role of Lexaria Bioscience

February 27, 2025

Via ACCESS Newswire

Ethics Board Approval Received for DehydraTECH-tirzepatide GLP-1 Study-Arm

February 24, 2025

Via ACCESS Newswire

Lexaria's Strategic Business Pursuit of DehydraTECH-Liraglutide

February 20, 2025

Via ACCESS Newswire

Lexaria Provides Update on Material Transfer Agreement with Pharmaceutical Company

May 12, 2025

Via ACCESS Newswire

Lexaria Announces Closing of $2 Million Registered Direct Offering of Common Stock

April 28, 2025

Via ACCESS Newswire

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.

April 25, 2025

Via Chartmill

Top stock movements in today's session.

April 25, 2025

Via Chartmill

Lexaria Granted Two New DehydraTECH Patents for Treatment of Epilepsy

February 11, 2025

Via ACCESS Newswire

Lexaria Biodistribution Study For DehydraTECH GLP-1 is Underway

February 06, 2025

Via ACCESS Newswire

Crude Oil Edges Higher; Phillips 66 Posts Wider-Than-Expected Loss

April 25, 2025

Via Benzinga

There are notable gap-ups and gap-downs in today's session.

April 25, 2025

Via Chartmill

These stocks that are showing activity before the opening bell on Friday.

April 25, 2025

Via Chartmill

Lexaria Updates its Ongoing Human Study GLP-1-H24-4

February 05, 2025

Via ACCESS Newswire

Dow Falls 200 Points; Alphabet Posts Upbeat Q1 Results

April 25, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session

April 25, 2025

Via Benzinga

Lexaria Announces $2 Million Registered Direct Offering of Common Stock

April 25, 2025

Via ACCESS Newswire

Recent GLP-1-Industry Developments Highlight the Promise of Lexaria Bioscience’s Technology

April 23, 2025

Via ACCESS Newswire

Lexaria Updates its Ongoing Human Study GLP-1-H24-4

April 03, 2025

Via ACCESS Newswire

Lexaria's Human GLP-1 Study #5 Begins Dosing

April 02, 2025

Via ACCESS Newswire

Lexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly’s Injectable Zepbound(R)

March 18, 2025

Via ACCESS Newswire

Frequently Asked Questions

Is Lexaria Bioscience Corp. - Common Stock publicly traded?

Yes, Lexaria Bioscience Corp. - Common Stock is publicly traded.

What exchange does Lexaria Bioscience Corp. - Common Stock trade on?

Lexaria Bioscience Corp. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Lexaria Bioscience Corp. - Common Stock?

The ticker symbol for Lexaria Bioscience Corp. - Common Stock is LEXX on the Nasdaq Stock Market

What is the current price of Lexaria Bioscience Corp. - Common Stock?

The current price of Lexaria Bioscience Corp. - Common Stock is 1.030

When was Lexaria Bioscience Corp. - Common Stock last traded?

The last trade of Lexaria Bioscience Corp. - Common Stock was at 07/24/25 12:17 PM ET

What is the market capitalization of Lexaria Bioscience Corp. - Common Stock?

The market capitalization of Lexaria Bioscience Corp. - Common Stock is 18.09M

How many shares of Lexaria Bioscience Corp. - Common Stock are outstanding?

Lexaria Bioscience Corp. - Common Stock has 18M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.